Roche records $2.8bn loss in 2002

October 27, 2003

Roche has recorded a $2.8 billion net loss for 2002 after writing off CHF9 billion costs following its embarrassing exit …

EU regulator submits expansion plans

October 27, 2003

Medicines regulator the EMEA has asked the European Union for a subsidy increase of nearly 13% to pay for its …

Bayer denies Lipobay cover-up

October 27, 2003

Bayer has refuted allegations that it concealed serious side-effects of its statin Lipobay before it was withdrawn in July 2001.US …

Pfizer picks US research ‘hotspot’ for trials centre

October 27, 2003

Pfizer is to build a new $35 million clinical research centre in an R&D 'hotspot' in New Haven, Connecticut.Due to …

Abbott surprised by early Humira approval

October 27, 2003

Abbott Laboratories says US approval of its rheumatoid arthritis product Humira has come earlier than expected, and will now increase …

ClinPhone signals European expansion

October 27, 2003

UK clinical trials technology company ClinPhone is to develop its European business to serve clusters of pharmaceutical and biotech companies …

GSK faces growing opposition to US parallel trade policy

October 27, 2003

GlaxoSmithKline is facing growing opposition from US patient groups and politicians to its attempt to block cheap drug imports from …

Milburn shortlists 50 hospitals for foundation status

October 27, 2003

Health Secretary Alan Milburn has shortlisted 50 hospitals he believes are ready to take on foundation status before the next …

AstraZeneca painkiller collaboration fails

October 27, 2003

The future of a potential new blockbuster pain killer under development by AstraZeneca is in doubt after it failed safety …

Lilly and Sankyo to share sales team

October 27, 2003

Eli Lilly and Sankyo Pharma UK are to share sales representatives in an innovative new arrangement co-ordinated by contract sales …

NHS promotes primary care drug dictionary

October 27, 2003

A campaign to raise PCT awareness of the new Primary Care Drug Dictionary (PCCD) has been launched to promote its …

Canada first market for Crestor

October 27, 2003

AstraZeneca's Crestor is to receive an immediate launch in its first market after Canada's regulator's approved the new cholesterol lowering …

Mixed Paxil patent news for GSK

October 27, 2003

GlaxoSmithKline has received mixed news in the on-going patent battle with Canadian generics company Apotex over its biggest selling drug, …

The Gateway to Local Adoption Series

Latest content